🙌 In Slovakia the first patient was enrolled in the new IVAC 2L Post-Market Clinical Follow-up (PMCF) by Dr. Milan Dragula at University Hospital Martin. The objective is to document the real-world experience on the use of iVAC 2L and the assessment of clinical outcomes at discharge, 30 days and longer.